Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.3100
+0.0137 (4.62%)
At close: May 20, 2026, 4:00 PM EDT
0.2801
-0.0299 (-9.65%)
After-hours: May 20, 2026, 7:58 PM EDT
Ensysce Biosciences Market Cap
Ensysce Biosciences has a market cap or net worth of $2.88 million as of May 20, 2026. Its market cap has decreased by -17.83% in one year.
Market Cap
2.88M
Enterprise Value
2.25M
1-Year Change
-17.83%
Ranking
Category
Stock Price
$0.31
Market Cap Chart
Since December 1, 2017, Ensysce Biosciences's market cap has decreased from $249.00M to $2.88M, a decrease of -98.84%. That is a compound annual growth rate of -40.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 4.30M | 30.30% |
| Dec 31, 2025 | 3.30M | -68.87% |
| Dec 31, 2024 | 10.60M | 221.21% |
| Dec 29, 2023 | 3.30M | -40.00% |
| Dec 30, 2022 | 5.50M | -95.18% |
| Dec 31, 2021 | 114.00M | 46.34% |
| Dec 31, 2020 | 77.90M | -70.10% |
| Dec 31, 2019 | 260.50M | 6.11% |
| Dec 31, 2018 | 245.50M | -0.89% |
| Dec 29, 2017 | 247.70M | -0.52% |
| Dec 1, 2017 | 249.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GRI Bio | 3.22M |
| Azitra | 3.08M |
| Indaptus Therapeutics | 2.98M |
| Adial Pharmaceuticals | 2.94M |
| BiomX | 2.93M |
| Calidi Biotherapeutics | 2.83M |
| Decoy Therapeutics | 2.82M |
| SciSparc | 2.57M |